Brain Mapping by Integrated Neurotechnologies for Disease Studies

ログイン Contact
  • ja
  • en

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.

posted : 2018.01.30

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.